Early treatment for HIV slows damage to immune system and reduces risk of transmission
A 48-week course of antiretroviral medication taken in the early stages of HIV infection slows the damage to the immune system and delays the need...
More news
IDIBAPS continues to grow with the CELLEX Biomedical Research Centre
The CELLEX Biomedical Research Center has been presented, a new space where professionals from the Institut d’Investigacions Biomèdiques August Pi...
Dr. Moisès Broggi i Vallès: A role model
The dawn of 30 December, Dr. Moises Broggi i Vallès died at 104 years in Barcelona. Dr. Broggi had a long career in which he was recognized with se...
A therapeutic dendritic cell vaccine for HIV-1 infection controls virus replication temporarily
Combination antiretroviral therapy (cART) is a success of modern medicine that greatly improves survival and quality of life of HIV-1–infected pat...
Studies from Hospital Clínic and IDIBAPS in the Spanish Science Top5 of the year
2012 is ending, a difficult year also for science due to the crisis affecting much of the world. Despite this, it's not all are bad news. The span...
Clínic and IDIBAPS participate in a record Marató
La Marató of TV3 (Catalan Telethon), this year dedicated to cancer, got on December 16 a new record of participation and collection. The 2,000 pop...
IDIBAPS – Hospital Clínic investigators lead a consensus statement on Plasma cell leukemia
Plasma cell leukemia (PCL) is a rare and aggressive variant of myeloma characterized by the presence of circulating plasma cells. It is classified...